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Abstract
Background: An impairment of cardiovascular function in streptozotocin (STZ)-diabetic rats has been mentioned
within 5 days-to-3 months of induction. ATP-sensitive potassium (KATP) channels are expressed on cardiac
sarcolemmal membranes. It is highly responsive to metabolic fluctuations and can have effects on cardiac
contractility. The present study attempted to clarify the changes of cardiac KATP channels in diabetic disorders.
Methods: Streptozotocin-induced diabetic rats and neonatal rat cardiomyocytes treated with a high concentration
of glucose (a D-glucose concentration of 30 mM was used and cells were cultured for 24 hr) were used to
examine the effect of hyperglycemia on cardiac function and the expression of KATP channels. KATP channels
expression was found to be linked to cardiac tonic dysfunction, and we evaluated the expression levels of KATP
channels by Western blot and Northern blot analysis.
Results: The result shows diazoxide produced a marked reduction of heart rate in control group. Furthermore, the
methods of Northern blotting and Western blotting were employed to identify the gene expression of KATP
channel. Two subunits of cardiac KATP channel (SUR2A and kir 6.2) were purchased as indicators and showed
significantly decreased in both diabetic rats and high glucose treated rat cardiac myocytes. Correction of
hyperglycemia by insulin or phlorizin restored the gene expression of cardiac KATP in these diabetic rats.
Conclusions: Both mRNA and protein expression of cardiac KATP channels are decreased in diabetic rats induced
by STZ for 8 weeks. This phenomenon leads to result in desensitization of some KATP channel drugs.
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Background
Diabetes is a disease characterized by chronic hypergly-
cemia secondary to a reduction in the functional efficacy
and/or a deficiency of insulin. In fact, patients with dia-
betes have a shorter life span and a lesser quality of life,
mainly as a result of macrovascular and/or microvascu-
lar complications[1]. An impairment of cardiovascular
function in streptozotocin (STZ)-diabetic rats has been
mentioned within 5 days-to-3 months of induction [2].
ATP-sensitive potassium (KATP) channels are
expressed on cardiac sarcolemmal membranes, and can
have effects on cardiac repolarization and contraction
during physiological and pathophysiological conditions
[3-5]. Sarcolemmal KATP channels are composed of a
pore-forming subunit (kir6.1 or kir6.2) and a sulfony-
lurea receptor (SUR1, SUR2A or SUR2B) [6]. Activation
of KATP channels plays an important role of cardio-pro-
tection during myocardial ischemia and hypoxia [7-9].
In the cardiac muscular cells, KATP channel gating is
highly responsive to metabolic fluctuations in the chan-
nel microenvironment[10]; the KATP could act as sensor
of cell energy metabolism. KATP channel senses signals
of cell energy metabolism in two ways. One is direct
interactions between KATP and cell metabolites, which
will produce immediate and temporal effects on channel
activities[11]; the other is regulation of KATP genes
expression by energy metabolism, this way can induce a
delayed but much profound effect on channel quantity
[12].
Cell energy metabolism regulates KATP genes expres-
sion; alternations in the metabolism will lead to changes
of the KATP channel number[12]. High glucose leads to
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pancreatic islets as well as in the INS-1 beta cell line.
This effect is reversed by exposure to low glucose[13].
Taken into together, investigation on the gene expres-
sion of cardiac KATP might clarify the cardiac dysfunc-
tion during diabetes development.
In order to demonstrate the changes of cardiac KATP
channels in diabetic disorders, the present study
employed the whole heart of diabetic rats induced by
STZ injection for 8 weeks and neonatal rat cardiomyo-
cytes. The alterations of cardiac KATP channels in the
protein and mRNA levels were employed as indicators.
Methods
Animals
Three-month-old male Wistar rats were housed in a
temperature controlled room (25°C) with a 12-h dark
and 12-h light cycle. Food and water were available at
its pleasure. Diabetic rats were prepared by giving an
intravenous (IV) injection of 60 mg/kg streptozotocin
(STZ) (Sigma-Aldrich, Inc., Saint Louis, Missouri, USA),
into the fasting rats. Animals were considered to be dia-
b e t i ci ft h e yh a dp l a s m ag l u c o s ec o n c e n t r a t i o n so f2 0
mmol/l or greater in addition to polyuria and other dia-
betic features. All studies were carried out 2 weeks after
the injection of STZ. The concentration of plasma glu-
cose was measured by the glucose oxidase method using
an analyzer (Quik-Lab, Ames, Miles Inc., Elkhart, Indi-
ana, USA). The animal experiment was approved and
conducted in accordance with local institutional guide-
lines for the care and use of laboratory animals in the
Chi-Mei Medical Center (No. 100052307) and con-
formed with the Guide for the Care and Use of Labora-
tory Animals (Kilkenny C et al. Improving bioscience
research reporting: the ARRIVE guidelines for reporting
animal research. PLoS Biol 2010, Jun 29;8(6):e1000412),
as well as the guidelines of the Animal Welfare Act.
Cell cultures
Primary cultures of neonatal rat cardiomyocytes were
prepared by modification of a previously described
method [14]. Briefly, under anaesthesia with pentobarbi-
tal (30 mg/Kg), the heart tissue from a 1- to 2-day-old
Wistar rat was excised then cut into 1-2 mm pieces and
predigested with trypsin to remove red blood cells. The
heart tissue was then digested with 0.25% trypsin and
0.05% collagenase. The dissociated cells were placed in
uncoated 100 mm dishes and incubated at 37°C in a 5%
CO2 incubator for at least 1 h to remove the non-myo-
cytic cells. This procedure caused fibroblasts to predo-
minantly attach to the dishes while most of the
cardiomyocytes remained unattached. The population of
cells enriched in cardiomyocytes was collected and
counted. The cells were cultured in Dulbecco/Vogt
modified Eagle’s minimal essential medium (DMEM)
with 1 mmol/L pyruvate, 10% foetal bovine serum
(FBS), 100 units/mL penicillin, and 100 units/mL strep-
tomycin. Using this protocol, > 95% of the cells were
deemed cardiomyocytes as judged by sarcomeric myosin
content. On the second day after plating, medium was
replaced. Three to 4 days after plating, the cells were
exposed to hyperglycaemic conditions. The high glu-
cose-treated cardiomyocytes were generated by treating
the cells with 30 mmol/L glucose for 24 h [15]. This
animal experiment was also approved and conducted in
accordance with local institutional guidelines for the
care and use of laboratory animals in the Chi-Mei Medi-
cal Center (No. 100052307) and followed the Guide for
the Care and Use of Laboratory Animals published by
the US National Institutes of Health (NIH Publication
No. 85-23, revised 1996), as well as the guidelines of the
Animal Welfare Act.
Blood pressure measurement
The systolic blood pressure (SBP) was monitored in rats
with diabetes 8 weeks after induction. The blood pres-
sure measurements in age-matched normal rats were
designated as controls. The blood pressure of the tail
artery was measured non-invasively with a photoelectric
volume oscillometer (UR-5000, Ueda, Japan) by placing
the tail cuff device around the tail of the rat. The mea-
surements for SBP were recorded in quadruplicate for
each rat and the average blood pressure was calculated.
The effect of diazoxide (DZ) on heart rate on diabetic rats
8 weeks after induction
DZ (Sigma-Aldrich, Inc.), the well-known opener of
KATP channels[16], was iv injected at 0.5, 1, 2 mg/kg for
diabetic rats and 3, 5, 8 mg/kg for normal rats. The
changes in heart rates were recorded at 5 minutes inter-
val for 30 minutes.
The effects of insulin and phlorizin on diabetic rats 8
weeks after induction
Normalization of hyperglycemia was achieved per a pre-
vious protocol [17] in rats with diabetes for 8 weeks,
using treatment either with 1 mg/kg of phlorizin dehy-
drate (Fluka Chemie, Buchs, Switzerland) or 0.5 IU of
insulin (Novo Nordisk, Bagsvaerd, Denmark) by ip injec-
tion every 8 h for 4 days. Fluctuations in blood glucose
levels were not observed in rats during repeated injec-
tions of insulin or phlorizin. Upon completion of treat-
ment, the rats were sacrificed and their hearts were
immediately removed, frozen in liquid nitrogen, and
stored at -70°C until analysis was performed. The SUR-
2A and Kir6.2 protein and mRNA concentrations in the
heart tissue were measured by Western immunoblotting
and Northern blotting, respectively. Blood samples were
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sacrifice to estimate alterations in plasma glucose.
Preparation of heart membrane fraction
The preparation of membrane fraction from whole heart
was performed on ice. The isolated heart tissue was
l y s e di n1 0m lo fp H7 . 4T r i s / E D T Ab u f f e ra t4 ° Ca n d
homogenized for 15 s. The membrane fraction was
obtained by centrifugation at 20,000 g for 15 min.
Measurement of KATP channel protein
After homogenization, the protein content was determined
by BioRad protein dye binding assay (Bio-Rad Labora-
tories, Richmond, CA, USA). Protein samples (9 μg) were
separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (10% acrylamide gel) using Bio-Rad Mini-
Protein II system (Laemmli 1970). The separated proteins
were blotted onto nitrocellulose. After treating with SUR-
2A and Kir6.2 antibody (Affinity Bioreagents, Inc., Color-
ado, USA). Immunostaining was performed for peroxidase
activity by incubation in Tris-buffer (10 mmol/l). The
intensity of the blot incubated with goat polyclonal anti-
body (1:1000) to bind actin (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA) was used to ensure that the
amount of protein loaded into each lane of the gel was
constant. Autoradiography was developed using an
enhanced chemiluminescence development system (Amer-
sham International, Buckinghamshire, UK). The resulting
immunoblots were quantified by a scanning densitometer
(Hoefer, San Francisco, CA, USA).
Measurement of KATP channel mRNA
Total RNA was extracted from heart using Ultraspec™-
II RNA extraction system (Bioteck, Houston, TX, USA)
as indication of the manufacturer. RNA (20 μg) was
denatured and aliquots of total RNA were then size-
fractionated in a 1.2% agarose/formaldehyde gel. The
RNA was transferred to a Hybond-N membrane (Amer-
sham International). SUR-2A and Kir6.2 mRNA levels
were detected using prime-labeled full-length cDNA
under stringent hybridization conditions [18]. Intensity
of the mRNA blot was quantified by scanning densito-
metry (Hoefer, San Francisco, CA, USA). The response
of b-actin was used as internal standard.
Statistical analysis
Statistical analysis was carried out using ANOVA analy-
sis and Newman-Keuls post-hoc analysis. Statistical sig-
nificance was set as p < 0.05. Results were expressed as
mean ± SE of each group from various samples (n).
Results
Changes of plasma glucose and systolic blood pressure in
rats with diabetes for 8 weeks
The fasting plasma glucose levels of STZ-diabetic rats were
significantly higher than those of untreated rats (Table 1).
Additionally, the plasma insulin mean level in diabetic rats
induced by STZ for 8 weeks was 13.4 ± 2.7 μU/ml (n =8 ) ,
markedly lower than the insulin level in control rats (58.3
±6 . 4μU/ml; n = 8). Moreover, the plasma glucose levels
in rats with diabetes for 8 weeks were markedly reversed
by treatment with either insulin or phlorizin for 4 days, as
compared to untreated diabetic rats (Table 1).
The SBP in diabetic rats induced by STZ for 8 weeks
was significantly lower than that in age-matched normal
rats. Injection of diabetic rats with 0.5 IU/kg insulin, three
times daily for 4 days, restored the SBP to a level
approaching normal control (Table 1). Similarly, treatment
with phlorizin for 4 days elevated the SBP in rats with dia-
betes for 8 weeks to 118.4 ± 2.9 mmHg, which was not
statistically different from the control rats (Table 1).
T h eb o d yw e i g h to fS T Z - d i a b e t i cr a t sw a sm a r k e d l y
less than that of normal control (Table 1). There was no
difference in the body weight of diabetic rats between
the vehicle- and insulin-treated groups throughout the
4-day study (Table 1). Also, phlorizin did not influence
t h eb o d yw e i g h ti nS T Z - d i a b e t i cr a t st h r o u g h o u tt h e4 -
day treatment (Table 1).
Effect of diazoxide (DZ) on the heart rate of rats
Figure 1 showed that DZ reduced the heart rates in both
STZ-diabetic and control rats. Also, heart rate decreased
Table 1 Changes of body weight, plasma glucose level and hemodynamic parameters in 8 weeks STZ-diabetic rats
received insulin (0
Body weight
(g/rat)
Plasma glucose
(mg/dl)
Blood pressure
(mmHg)
Heart rate
(bpm)
Normal rats
Vehicle-treated 252.6 ± 8.7 93.4 ± 7.5 119.4 ± 3.3 358.4 ± 9.3
Diabetic rats
Vehicle-treated 182.3 ± 7.5** 348.2 ± 11.3*** 96.3 ± 2.7* 320.2 ± 7.6*
Insulin-treated 189.4 ± 6.3** 223.6 ± 9.8** 114.2 ± 3.4 338.7 ± 10.2
Phlorizin-treated 184.6 ± 7.2** 248.1 ± 8.7** 118.4 ± 2.9 341.6 ± 8.3
Values are the mean ± SE for each group of 8 animals. * P < 0.05, ** P < 0.01, and *** P < 0.001 levels of significance, as compared to the values in normal rats
that received treatment with vehicle in the same volume.
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of 0.5 mg/kg was more pronounced than that (2.6 ±
1.2%) in normal rats responding to 3 mg/kg DZ.
Changes in mRNA levels of cardiac KATP channels in rats
with diabetes for 8 weeks
The mRNA levels of cardiac SUR-2A and Kir6.2 were
significantly decreased in diabetic rats that received STZ
for 8 weeks as compared to the age-matched normal
rats (Figure 2). This decrease in cardiac SUR-2A and
Kir6.2 mRNA levels of rats with diabetes for 8 weeks
was reversed after 4 days of insulin treatment to
approximately the same level which existed in control
rats. Treatment of these diabetic rats with 4 days of
phlorizin also reversed the mRNA levels of SUR-2A and
Kir6.2 in cardiac tissue to approximately 67% of the
level compared with vehicle-treated diabetic rats (Figure
2).
Changes in protein and mRNA levels of cardiac KATP
channels in rats with diabetes for 8 weeks
The protein levels of cardiac SUR-2A and Kir6.2 in rats
8 weeks after STZ injection were markedly decreased to
nearly 2-fold the levels in aged-matched controls (Figure
3). After 4 days of insulin injections, the cardiac SUR-
2A and Kir6.2 protein levels in these diabetic rats were
approximately 60% reversed than that in vehicle-treated
diabetic rats (Figure 3). A marked recovery in the pro-
tein level of SUR-2A and Kir6.2 was also observed in
the cardiac tissues of rats with diabetes for 8 weeks after
a 4-day treatment of phlorizin, which was 64% of the
level measured in the vehicle-treated diabetic rats (Fig-
ure 3).
Decrease of KATP channels expression levels by glucose in
neonatal rat cardiac myocytes
Effects of hyperglycemia on SUR-2A and Kir6.2 expres-
sion levels were further characterized by exposing cul-
tured neonatal rat cardiac myocytes to various
concentrations of glucose in vitro. The SUR-2A and
Kir6.2 expression levels in neonatal rat cardiac myocytes
were reduced in a concentration-dependent manner
when cultured in media containing glucose after 24 hr
incubation. The lack of change in SUR-2A and Kir6.2
expression levels in mannitol treated neonatal rat car-
diac myocytes showed that protein expression levels
were not affected by hyperosmolarity. Thus, we identi-
fied that expression levels of SUR-2A and Kir6.2 are
decreased by high glucose in neonatal rat cardiac myo-
cytes, similar to the changes observed in heart of dia-
betic rats (Figure 4).
Restored of KATP channels expression levels in high-
glucose treated neonatal rat cardiac myocytes by free
radicals scavenger
Free radicals (ROS) are excessively produced in the
pathogenesis of acute and diseases[19]. Present studies
have demonstrated that cardiac dysfunction is caused by
increasing of ROS production in hyperclycemic rats and
high-glucose treated cardiac myocytes. To investigate
the effect of hyperglycemia on SUR-2A and Kir6.2
expression, we treated neonatal rat cardiac myocytes
Figure 1 Effects of KATP channel opener, diazoxide (DZ), on the heart rates inS T Z - d i a b e t i cr a t sw i t h8w e e k so fd i a b e t e s( c l o s e d
circles) and Wistar rats (open circles). Diabetic rats were iv injected with DZ at 0.5, 1 or 2 mg/kg. Wistar rats were received same treatment
with DZ at 3, 5 or 8 mg/kg. The results are expressed as the mean ± SE obtained from each group of 7 animals. * P < 0.05 and ** P < 0.01 for
comparisons of the post-injection heart rates with the pre-injection baseline heart rate (0) in each group.
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medium with and without 100 nmol of tiron, a superox-
ide anion scavenger[20] and after incubation we exam-
ined the effects on SUR-2A and Kir6.2 expression using
w e s t e r nb l o ta n a l y s i s( F i g u r e5 ) .W eo b s e r v e dt h a tt h e
decreased SUR-2A and Kir6.2 protein expressions in
neonatal rat cardiac myocytes caused by high glucose
concentrations were reversed by tiron treatment (Figure
5); these are consistent with our previous observations
of SUR-2A and Kir6.2.
Discussion
Due to the difference between human and animal and/
or the stage of diabetes, the response of blood pressure
is varied; changes of blood pressure in diabetic compli-
cations seem not so simple. Numerous evidences sug-
gest that diabetic heart is characterized by compromised
ventricular contraction and prolonged relaxation attribu-
table to multiple causative factors including calcium
accumulation, oxidative stress and apoptosis. Previous
study have demonstrated that blocking the calcium
channel and oxidative stress could have advantage in
diabetic heart [21]. Another study also showed that
hyperglycemia can cause systolic dysfunction and a
higher expression of cTnI in cardiomyocytes through
ROS, enhancing MEK/ERK-induced GATA-4 phosphor-
ylation and accumulation in the cell nucleus [22].
Although chronic diabetes is commonly linked to hyper-
tension[23], hypotension has been ubiquitously
described in early stage of diabetes[24,25]. In the present
study, cardiac dysfunction as evidenced by bradycardia
and hypotension has been observed early in the course
of diabetic rats receiving STZ for 8 weeks. Similar car-
diac pathology in spontaneously diabetic Bio-Breeding
rats has also been reported; specifically, the heart rate
and heart rate variability were significantly lower than
the control rats [26].
We showed that the mRNA level of cardiac KATP
channels in rats with diabetes for 8 weeks duration was
markedly lower than in non-diabetic rats. Also, changes
in the protein level of cardiac KATP channels were asso-
ciated with steady-state levels of mRNA encoding this
receptor. A decrease of cardiac KATP gene expression
was observed during the early stage of type-1 like dia-
betes. It is well known that the most prominent role of
KATP channels in cardiovascular system is that opening
of this channel can protect cardiac myocytes against
ischemic injuries [27]. Actually, the effect of diazoxide
Figure 2 Effects of insulin or phlorizin on the gene expression of cardiac KATP channels in STZ-treated rats with 8 weeks of diabetes.
The upper panel is the autoradiograph resulting from Northern blotting of the cardiac SUR-2A (A), Kir6.2 (B) mRNA or b-actin in hearts isolated
from these diabetic rats treated with insulin (0.5 IU) or phlorizin (1 mg/kg) three times daily for 4 days. The vehicle used to dissolve the test
medications was given in the same volume. Similar results were obtained with an additional 5 replications. Quantification of mRNA levels using
SUR-2A or Kir6.2/b-actin, expressed as mean with SE (n = 6 per group) in each column, is indicated in the lower panel. * P < 0.05, ** P < 0.01
and *** P < 0.001 vs. control.
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decreased in rats with diabetes for 8 weeks duration.
Therefore, decreased expression of cardiac KATP channel
is one of the mechanisms accounting for cardiac dys-
function in the early stage of diabetes.
Several mechanisms have been proposed to explain
the pathogenesis of diabetic complications, and hyper-
glycemia is always implicated [28]. Abnormal sympa-
thetic nervous system and b-adrenoceptor (b-AR)
signaling is associated with diabetes. b-AR have been
found reduced the expression under Hyperglycemia
[29]. In an attempt to know the role of hyperglycemia
and/or hypoinsulinemia in the changes of cardiac KATP
channels in insulin-deficient diabetic rats, exogenous
insulin was administrated for 4 days into the diabetic
rats, 8 weeks following induction with STZ. We found
that insulin treatment of diabetic rats reversed the blood
pressure reduction. In addition, normalization of plasma
glucose level with insulin had a tendency to reverse the
lower expression of cardiac KATP channels in 8 weeks
diabetic rats. Phlorizin is an inhibitor of the renal tubu-
lar reabsorption of glucose and it has been widely used
to distinguish the role of hyperglycemia in STZ-diabetic
rats [30]. The reductions in blood pressure as well as
the lowerer gene expression of cardiac KATP in these
diabetic rats were also reversed by the reduction of
hyperglycemia from phlorizin injection. Therefore,
hyperglycemia is related to the down-regulation of car-
diac KATP channels during the early stage of diabetes. In
the present study, similar changes of KATP channels
were observed on the whole heart of experimental dia-
betes, instead of limiting to atria or ventricles. Hypergly-
cemia could be considered a key in cardiac alteration
that was associated with the decrease in cardiac KATP
channels gene expression, leading to result in hypoten-
sion observed in 8 weeks type-1 diabetic rats.
We also demonstrated that expression levels of SUR-
2A and Kir6.2 are decreased by high glucose in neonatal
rat cardiac myocytes, similar to the changes observed in
heart of diabetic rats. Furthermore, in cultured neonatal
rat cardiac myocytes, the reduced expressions of SUR-
2A and Kir6.2 caused by high concentrations of glucose
were also reversed by the antioxidant tiron.
Clinically, heart disease is one of the major causes of
death in diabetic patients, due in part to the accumula-
tion of advanced glycation end products (AGE) resulting
from chronic hyperglycemia [31]. AGE is known to pro-
duce from various pathways such as lipid peroxidation
or oxidative stress, in addition to the underlying glyce-
mia and accumulation in blood and tissues at an extre-
mely accelerated rate, which is correlated with the time
course of diabetes [32]. It has been suggested that
Figure 3 Effects of insulin or phlorizin on the protein levels of cardiac KATP channels in STZ-treated rats with 8 weeks of diabetes.
Upper panel depicts the Western blot analysis of representative protein levels for SUR-2A or Kir6.2, actin in hearts isolated from these diabetic
rats treated in same manner. Quantification of protein levels using SUR-2A or Kir6.2/actin, expressed as mean with SE (n = 6 per group) in each
column, is indicated in the lower panel. * P < 0.05, ** P < 0.01 and *** P < 0.001 vs. control.
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Page 6 of 9Figure 4 Changes in expression of KATP channels in neonatal rat cardiac myocytes after exposure to high concentrations of glucose.
Cultured neonatal rat cardiac myocytes exposed to glucose at final concentrations of 10 mM, 20 mM and 30 mM were used to compare with
the control, which was incubated with 5.5 mM glucose. Cells were also exposed to 24.5 mM mannitol to produce the same osmolarity (317
mOsmol/L) as that produced when using the highest concentration of glucose (30 mM). After 24 hours of incubation, cells were prepared for
Western blot analysis. Quantification of protein levels using SUR-2A or Kir6.2 over b-actin indicated as means with SE (n = 4 per group) in each
column are presented in the lower panel. *P < 0.05, **P < 0.001 compared to control.
Figure 5 Effects of tiron on the protein levels of cardiac KATP channels in high-glucose treated neonatal rat cardiac myocytes. Cultured
neonatal rat cardiac myocytes exposed to glucose at final concentrations of 30 mM were used to compare with the control, which was
incubated with 5.5 mM menitol. Cells were also exposed to 100 nM tiron as radical scavenger. After 24 hours of incubation, cells were prepared
for Western blot analysis. Quantification of protein levels using SUR-2A or Kir6.2 over b-actin indicated as means with SE (n = 4 per group) in
each column are presented in the lower panel. *P < 0.05, **P < 0.001 compared to control.
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years does not lead to an effective reduction in AGE
levels, illustrating the negative correlation between
hyperglycemia and the advanced diabetic complications
that occur in chronic diabetes[32]. It appears that hyper-
glycemia may decrease cardiac KATP channels gene
expression to account for the changes of cardiovascular
function during the early stage of diabetes [28]. Thus,
more studies are necessary to clarify the detailed
mechanism(s) in the near future. The current study sup-
ports the recommendations for glycemic control of dia-
betes at early stage to lower complications.
Conclusions
We have demonstrated that both mRNA and protein
expression of cardiac KATP channels are decreased in
diabetic rats induced by STZ for 8 weeks. This phenom-
enon leads to reduction of blood pressure. Correction of
hyperglycemia by insulin or phlorizin restored the gene
expression of cardiac KATP in these diabetic rats. These
data suggest that an increase of plasma glucose may
enhance cardiac KATP channels gene expression to result
in cardiac dysfunction observed in diabetic rats.
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